Replies to post #58527 on Biotech Values

[stuck_holder]

iwfal, interesting that you have followed this company, though i think that has to be due only to its science, certainly not its management.

Another word of caution re: Thompson

the company issued a press release back in early 2001 headlining that they had filed for their first Phase II trial (in Canada for prostate cancer).

this trial was subsequently re-characterized by the company several years later as a "proof of concept", after ending it prematurely even tho they took a couple of years to partially enroll something like 6 or 12 patients!!!

When I personally spoke to Thompson about this he suggested it never was a Phase II trial and had never been represented as such, which I later learned was contrary to the contents of the earlier press release.